| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.6 |